Concepedia

Madlaina Breuleux

MB

Statistics

Publications

6

Citations

456

H-Index

6

Active since

2006

Affiliations

Novartis (Switzerland)(Current)

Roche (Switzerland)

Madlaina Breuleux is an author at Novartis (Switzerland) specializing in oncology, medicine, and signal transduction.

Publications per year

2006–2019

6

Publications

6

Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition

Madlaina Breuleux, Matthieu Klopfenstein, Christine Stephan et al. · Molecular Cancer Therapeutics · 2009 · 241 citations · Full text

, , +14

The Ret Receptor Tyrosine Kinase Pathway Functionally Interacts with the ERα Pathway in Breast Cancer

Anne Boulay, Madlaina Breuleux, Christine Stephan et al. · Cancer Research · 2008 · 124 citations · Full text

, , +17

Recombinant Adeno-Associated Viral Vectors Are Deficient in Provoking a DNA Damage Response

Michalis Fragkos, Madlaina Breuleux, Nathalie Clément et al. · Journal of Virology · 2008 · 43 citations · Full text

, , +17

Heregulins Implicated in Cellular Functions Other Than Receptor Activation

Madlaina Breuleux, Fabrice Schoumacher, Daniel Rehn et al. · Molecular Cancer Research · 2006 · 23 citations · Full text

, , +13

Outcomes of Ibrutinib (Ibr) Therapy in Ibr-Naïve Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Progressing after Venetoclax (Ven)

Jennifer R. Brown, Matthew S. Davids, Julie Chang et al. · Blood · 2019 · 13 citations

, , +14

1–5 of 6